Drugging the heat shock factor 1 pathway: Exploitation of the critical cancer cell dependence on the guardian of the proteome

Cell Cycle

Volumn 8, Issue 23, 2009, Pages 3806-3808

  De Billy, Emmanuel ^a   Powers, Marissa V ^a   Smith, Jennifer R ^a   Workman, Paul ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN; BORTEZOMIB; CISPLATIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; MEPACRINE; PROTEOME; QUERCETIN; TRIPTOLIDE;

CANCER CELL; CANCER THERAPY; CELL PROLIFERATION; CELL STRESS; CELL TRANSDIFFERENTIATION; DNA BINDING; FIBROSARCOMA; GENE EXPRESSION; HUMAN; MELANOMA; NONHUMAN; SHORT SURVEY;

EID: 74849095191     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.23.10423     Document Type: Short Survey

References (18)

1. Powers MV, et al. FEBS Lett. 2007; 581:3758-69.
2. Whitesell L, et al. Expert Opin Ther Targets 2009; 13:469-78.
3. Westerheide SD, et al. J Biol Chem 2005; 280:33097-100.
4. Dai C, et al. Cell 2007; 130:1005-18.
5. Powers MV, et al. Cancer Cell 2008; 14:250-62.
6. Au Q, et al. J Biomol Screen 2009; doi:10.1177/1087057109347472.
7. Zaarur N, et al. Cancer Res 2006; 66:1783-91.
8. Neznanov N, et al. Cell Cycle 2009; In press.
9. Guettouche T, et al. BMC Biochem. 2005; 6:4.
10. Huang Y, et al. Drug Metab Dispos 2006; 34:1136-44.
11. Workman P, et al. Ann NY Acad Sci 2007; 1113:202-16.
12. Solimini NL, et al. Cell 2007; 130:986-8.
13. Wang RE, et al. J Med Chem 2009; 52:1912-21.
14. Yokota S, et al. Cancer Res 2000; 60: 2942-8.
15. McCollum AK, et al. Mol Cancer Ther 2008; 7:3256-64.
16. Westerheide SD, et al. J Biol Chem 2006; 281:9616-22.
17. Vispe S, et al. Mol Cancer Ther 2009; 8:2780-90.
18. Chau NM, et al. Cancer Res. 2005; 65:4918-28.